144 related articles for article (PubMed ID: 29444929)
1. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
[No Abstract] [Full Text] [Related]
2. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
[TBL] [Abstract][Full Text] [Related]
3. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
[TBL] [Abstract][Full Text] [Related]
4. Prediction of lymph node involvement in patients with breast tumors measuring 3-5 cm in a middle-income setting: the role of CancerMath.
Pijnappel EN; Bhoo-Pathy N; Suniza J; See MH; Tan GH; Yip CH; Hartman M; Taib NA; Verkooijen HM
World J Surg; 2014 Dec; 38(12):3133-7. PubMed ID: 25167896
[TBL] [Abstract][Full Text] [Related]
5. Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models.
Laas E; Mallon P; Delomenie M; Gardeux V; Pierga JY; Cottu P; Lerebours F; Stevens D; Rouzier R; Reyal F
Br J Cancer; 2015 Mar; 112(5):912-7. PubMed ID: 25590666
[TBL] [Abstract][Full Text] [Related]
6. A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients.
Polchai N; Sa-Nguanraksa D; Numprasit W; Thumrongtaradol T; O-Charoenrat E; O-Charoenrat P
Cancer Manag Res; 2020; 12():5549-5559. PubMed ID: 32753968
[TBL] [Abstract][Full Text] [Related]
7. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
8. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
[TBL] [Abstract][Full Text] [Related]
9. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
10. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
11. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
14. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
[TBL] [Abstract][Full Text] [Related]
16. A simplified breast cancer prognostic score: comparison with the AJCC clinical prognostic staging system.
Fei F; Zhang K; Siegal GP; Wei S
Mod Pathol; 2021 Dec; 34(12):2141-2147. PubMed ID: 34365462
[TBL] [Abstract][Full Text] [Related]
17. A nomogram for determining the disease-specific survival in invasive lobular carcinoma of the breast: A population study.
Fu R; Yang J; Wang H; Li L; Kang Y; Kaaya RE; Wang S; Lyu J
Medicine (Baltimore); 2020 Oct; 99(43):e22807. PubMed ID: 33120801
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
19. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
[TBL] [Abstract][Full Text] [Related]
20. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
